{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:29:38Z","timestamp":1792783778360,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81801169"],"award-info":[{"award-number":["81801169"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82001303"],"award-info":[{"award-number":["82001303"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82371255\uff0c82071258"],"award-info":[{"award-number":["82371255\uff0c82071258"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81870952"],"award-info":[{"award-number":["81870952"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Program for Shanghai Outstanding Academic Leaders","award":["23XD1402500"],"award-info":[{"award-number":["23XD1402500"]}]},{"name":"Shanghai Science and Technology Innovation Action Plan","award":["23DZ2291500"],"award-info":[{"award-number":["23DZ2291500"]}]},{"name":"Program for Outstanding Medical Academic Leader of Shanghai","award":["2022LJ011"],"award-info":[{"award-number":["2022LJ011"]}]},{"name":"Training program for research physicians of innovative translational ability","award":["SHDC2022CRD037"],"award-info":[{"award-number":["SHDC2022CRD037"]}]},{"name":"Project of Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine","award":["ynnkxyb202412"],"award-info":[{"award-number":["ynnkxyb202412"]}],"id":[{"id":"https:\/\/ror.org\/0220qvk04","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Shanghai","award":["24ZR1457100"],"award-info":[{"award-number":["24ZR1457100"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05568-0","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:16:43Z","timestamp":1778663803000},"page":"2833-2849","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Semaglutide ameliorates neuroinflammation and cognitive impairment in APP\/PS1 mice"],"prefix":"10.1007","volume":"481","author":[{"given":"Yuan","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyu","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Juan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"5568_CR1","first-page":"186","volume":"20","author":"X Xiong","year":"2023","unstructured":"Xiong X, James BT, Boix CA et al (2023) Epigenomic dissection of Alzheimer\u2019s disease pinpoints causal variants and reveals epigenome erosion. Cell 20:186","journal-title":"Cell"},{"key":"5568_CR2","first-page":"112","volume":"3","author":"A Litvinchuk","year":"2024","unstructured":"Litvinchuk A, Suh JH, Guo JL et al (2024) Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist. Neuron 3:112","journal-title":"Neuron"},{"key":"5568_CR3","first-page":"7","volume":"1","author":"HL Wan","year":"2022","unstructured":"Wan HL, Zhang BG, Chen C et al (2022) Recombinant human erythropoietin ameliorates cognitive dysfunction of APP\/PS1 mice by attenuating neuron apoptosis via HSP90\u03b2. Signal Transduct Target Ther 1:7","journal-title":"Signal Transduct Target Ther"},{"key":"5568_CR4","first-page":"10","volume":"32","author":"X Wang","year":"2023","unstructured":"Wang X, Zhou R, Sun X et al (2023) Preferential Regulation of \u0393-Secretase-Mediated Cleavage of APP by Ganglioside GM1 Reveals a Potential Therapeutic Target for Alzheimer\u2019s Disease. Adv Sci (Weinh) 32:10","journal-title":"Adv Sci (Weinh)"},{"issue":"12","key":"5568_CR5","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s13238-021-00858-3","volume":"10","author":"X Xu","year":"2021","unstructured":"Xu X, Sun Y, Cen X et al (2021) Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model. Protein Cell 10(12):769\u2013787","journal-title":"Protein Cell"},{"key":"5568_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/13872877251374353","volume":"1","author":"A Kakkar","year":"2025","unstructured":"Kakkar A, Singh H, Singh BK et al (2025) Neuroinflammation and Alzheimer\u2019s disease: unravelling the molecular mechanisms. J Alzheimers Dis 1:19\u201341","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"5568_CR7","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s11064-012-0708-2","volume":"37","author":"JS Rao","year":"2012","unstructured":"Rao JS, Kellom M, Kim HW et al (2012) Neuroinflammation and synaptic loss. Neurochem Res 37(5):903\u2013910","journal-title":"Neurochem Res"},{"key":"5568_CR8","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"7434","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A et al (2013) NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature 7434:674\u2013678","journal-title":"Nature"},{"key":"5568_CR9","doi-asserted-by":"crossref","unstructured":"Wu L, Xian X, Xu G et al (2022) (2022) Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer\u2019s Disease, Mediators Inflamm. : 7924199","DOI":"10.1155\/2022\/7924199"},{"key":"5568_CR10","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.4103\/1673-5374.303016","volume":"8","author":"ML Dallas","year":"2021","unstructured":"Dallas ML, Widera D (2021) TLR2 and TLR4-mediated inflammation in Alzheimer\u2019s disease: self-defense or sabotage? Neural Regen Res 8:1552\u20131553","journal-title":"Neural Regen Res"},{"key":"5568_CR11","first-page":"14","volume":"3","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV (2018) Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 3:14","journal-title":"Nat Rev Neurol"},{"key":"5568_CR12","first-page":"24","volume":"22","author":"AE Alkhalifa","year":"2023","unstructured":"Alkhalifa AE, Al-Ghraiybah NF, Odum J et al (2023) Blood-Brain Barrier Breakdown in Alzheimer\u2019s Disease: Mechanisms and Targeted Strategies. Int J Mol Sci 22:24","journal-title":"Int J Mol Sci"},{"key":"5568_CR13","first-page":"341","volume":"6151","author":"JA Hagar","year":"2013","unstructured":"Hagar JA, Powell DA, Aachoui Y et al (2013) Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock. Science 6151:341","journal-title":"Science"},{"key":"5568_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature13683","volume":"7521","author":"J Shi","year":"2014","unstructured":"Shi J, Zhao Y, Wang Y et al (2014) Inflammatory caspases are innate immune receptors for intracellular LPS. Nature 7521:187\u2013192","journal-title":"Nature"},{"key":"5568_CR15","first-page":"57","volume":"12","author":"S Liu","year":"2020","unstructured":"Liu S, Gao J, Zhu M et al (2020) Gut Microbiota and Dysbiosis in Alzheimer\u2019s Disease: Implications for Pathogenesis and Treatment. Mol Neurobiol 12:57","journal-title":"Mol Neurobiol"},{"key":"5568_CR16","first-page":"4","volume":"5","author":"M Bomba","year":"2013","unstructured":"Bomba M, Ciavardelli D, Silvestri E et al (2013) Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals. Cell Death Dis 5:4","journal-title":"Cell Death Dis"},{"key":"5568_CR17","first-page":"S47","volume":"10","author":"C H\u00f6lscher","year":"2014","unstructured":"H\u00f6lscher C (2014) The incretin hormones glucagonlike peptide 1 and glucose-dependent insulinotropic polypeptide are neuroprotective in mouse models of Alzheimer\u2019s disease. Alzheimers Dement 1 Suppl 10:S47\u201354","journal-title":"Alzheimers Dement 1 Suppl"},{"key":"5568_CR18","first-page":"36","volume":"1","author":"CK Wong","year":"2024","unstructured":"Wong CK, McLean BA, Baggio LL et al (2024) Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation. Cell Metab 1:36","journal-title":"Cell Metab"},{"key":"5568_CR19","first-page":"58","volume":"18","author":"J Lau","year":"2015","unstructured":"Lau J, Bloch P, Sch\u00e4ffer L et al (2015) Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide. J Med Chem 18:58","journal-title":"J Med Chem"},{"key":"5568_CR20","first-page":"9","volume":"4","author":"KC Carlsson Petri","year":"2018","unstructured":"Carlsson Petri KC, Ingwersen SH, Flint A et al (2018) Semaglutide s.c. Once-Weekly in Type 2 Diabetes: A Population Pharmacokinetic Analysis. Diabetes Ther 4:9","journal-title":"Diabetes Ther"},{"key":"5568_CR21","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.2147\/DDDT.S470826","volume":"18","author":"XD Yang","year":"2024","unstructured":"Yang XD, Yang YY (2024) Clinical Pharmacokinetics of Semaglutide: A Systematic Review. Drug Des Devel Ther 18:2555\u20132570","journal-title":"Drug Des Devel Ther"},{"key":"5568_CR22","doi-asserted-by":"publisher","first-page":"102554","DOI":"10.1016\/j.redox.2022.102554","volume":"58","author":"J Zhang","year":"2022","unstructured":"Zhang J, Liu L, Zhang Y et al (2022) ChemR23 signaling ameliorates cognitive impairments in diabetic mice via dampening oxidative stress and NLRP3 inflammasome activation. Redox Biol 58:102554","journal-title":"Redox Biol"},{"key":"5568_CR23","doi-asserted-by":"publisher","first-page":"815562","DOI":"10.3389\/fnagi.2021.815562","volume":"13","author":"J Zhang","year":"2021","unstructured":"Zhang J, Zhang Y, Yuan Y et al (2021) Gut Microbiota alteration is associated with cognitive deficits in genetically diabetic (Db\/db) mice during aging. Front Aging Neurosci 13:815562","journal-title":"Front Aging Neurosci"},{"key":"5568_CR24","doi-asserted-by":"publisher","unstructured":"WilsonK (2001) Preparation of genomic DNA from bacteria. Curr Protoc Mol Biol Chapter 2:Unit 2.4. https:\/\/doi.org\/10.1002\/0471142727.mb0204s56","DOI":"10.1002\/0471142727.mb0204s56"},{"key":"5568_CR25","first-page":"37","volume":"8","author":"E Bolyen","year":"2019","unstructured":"Bolyen E, Rideout JR, Dillon MR et al (2019) Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol 8:37","journal-title":"Nat Biotechnol"},{"key":"5568_CR26","first-page":"13","volume":"7","author":"BJ Callahan","year":"2016","unstructured":"Callahan BJ, McMurdie PJ, Rosen MJ et al (2016) DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods 7:13","journal-title":"Nat Methods"},{"key":"5568_CR27","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast C, Pruesse E, Yilmaz P et al (2013) The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res Database issue 41:D590\u2013D596","journal-title":"Nucleic Acids Res Database issue"},{"key":"5568_CR28","doi-asserted-by":"publisher","first-page":"102484","DOI":"10.1016\/j.redox.2022.102484","volume":"57","author":"SP Rao","year":"2022","unstructured":"Rao SP, Xie W, Christopher Kwon YI et al (2022) Sulfanegen stimulates 3-mercaptopyruvate sulfurtransferase activity and ameliorates Alzheimer\u2019s disease pathology and oxidative stress in vivo. Redox Biol 57:102484","journal-title":"Redox Biol"},{"key":"5568_CR29","doi-asserted-by":"crossref","unstructured":"Tan MS, Tan L, Jiang T et al ((2014)) Amyloid-\u03b2 induces NLRP1-dependent neuronal pyroptosis in models of Alzheimer\u2019s disease. Cell Death Dis 8. 5: e1382","DOI":"10.1038\/cddis.2014.348"},{"key":"5568_CR30","doi-asserted-by":"crossref","unstructured":"Mejias NH, Martinez CC, Stephens ME et al (2018) Contribution of the inflammasome to inflammaging. J Inflamm (Lond). 15 : 23","DOI":"10.1186\/s12950-018-0198-3"},{"key":"5568_CR31","doi-asserted-by":"publisher","first-page":"167034","DOI":"10.1016\/j.scitotenv.2023.167034","volume":"905","author":"L Buchenauer","year":"2023","unstructured":"Buchenauer L, Haange SB, Bauer M et al (2023) Maternal exposure of mice to glyphosate induces depression- and anxiety-like behavior in the offspring via alterations of the gut-brain axis. Sci Total Environ 905:167034","journal-title":"Sci Total Environ"},{"key":"5568_CR32","doi-asserted-by":"crossref","unstructured":"Dunham SJB, McNair KA, Adams ED et al (2022) Longitudinal Analysis of the Microbiome and Metabolome in the 5xfAD Mouse Model of Alzheimer\u2019s Disease, mBio 6. 13 : e0179422","DOI":"10.1128\/mbio.01794-22"},{"key":"5568_CR33","doi-asserted-by":"crossref","unstructured":"Chen Y, Chen X, Luo Z et al (2024) Exercise-Induced Reduction of IGF1R Sumoylation Attenuates Neuroinflammation in APP\/PS1 Transgenic Mice. J Adv Res 69:279\u2013297.","DOI":"10.1016\/j.jare.2024.03.025"},{"key":"5568_CR34","doi-asserted-by":"publisher","first-page":"102846","DOI":"10.1016\/j.redox.2023.102846","volume":"66","author":"M Sangineto","year":"2023","unstructured":"Sangineto M, Ciarnelli M, Cassano T et al (2023) Metabolic reprogramming in inflammatory microglia indicates a potential way of targeting inflammation in Alzheimer\u2019s disease. Redox Biol 66:102846","journal-title":"Redox Biol"},{"key":"5568_CR35","doi-asserted-by":"crossref","unstructured":"Zhu Z, Zhang L, Elsherbini A et al (2023) The S1P receptor 1 antagonist Ponesimod reduces TLR4-induced neuroinflammation and increases A\u03b2 clearance in 5XFAD mice, EBioMedicine. 94 : 104713","DOI":"10.1016\/j.ebiom.2023.104713"},{"key":"5568_CR36","first-page":"19","volume":"1","author":"GC Brown","year":"2024","unstructured":"Brown GC, Heneka MT (2024) The endotoxin hypothesis of Alzheimer\u2019s disease. Mol Neurodegener 1:19","journal-title":"Mol Neurodegener"},{"key":"5568_CR37","first-page":"20","volume":"1","author":"TJ Petrisko","year":"2023","unstructured":"Petrisko TJ, Gargus M, Chu SH et al (2023) Influence of complement protein C1q or complement receptor C5aR1 on gut microbiota composition in wildtype and Alzheimer\u2019s mouse models. J Neuroinflammation 1:20","journal-title":"J Neuroinflammation"},{"issue":"19","key":"5568_CR38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12933-020-01070-z","volume":"1","author":"OM Alfayez","year":"2020","unstructured":"Alfayez OM, Almohammed OA, Alkhezi OS et al (2020) Indirect comparison of glucagon like peptide-1 receptor agonists regarding cardiovascular safety and mortality in patients with type 2 diabetes mellitus: network meta-analysis. Cardiovasc Diabetol 1(19):96","journal-title":"Cardiovasc Diabetol"},{"key":"5568_CR39","first-page":"13","volume":"1","author":"Q Ma","year":"2018","unstructured":"Ma Q, Zhao Z, Sagare AP et al (2018) Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-\u03b242 by LRP1-dependent apolipoprotein E isoform-specific mechanism. Mol Neurodegener 1:13","journal-title":"Mol Neurodegener"},{"key":"5568_CR40","first-page":"20","volume":"1","author":"M Vulin","year":"2023","unstructured":"Vulin M, Zhong Y, Maloney BJ et al (2023) Proteasome inhibition protects blood-brain barrier P-glycoprotein and lowers A\u03b2 brain levels in an Alzheimer\u2019s disease model. Fluids Barriers CNS 1:20","journal-title":"Fluids Barriers CNS"},{"key":"5568_CR41","first-page":"1300","volume":"6","author":"ZK Xing","year":"2023","unstructured":"Xing ZK, Du LS, Fang X et al (2023) The relationship among amyloid-\u03b2 deposition, sphingomyelin level, and the expression and function of P-glycoprotein in Alzheimer\u2019s disease pathological process. Neural Regen Res 6:1300\u20131307","journal-title":"Neural Regen Res"},{"issue":"3","key":"5568_CR42","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s42255-020-00327-x","volume":"2","author":"FM Gribble","year":"2021","unstructured":"Gribble FM, Reimann F (2021) Metabolic Messengers: glucagon-like peptide 1. Nat Metab 2(3):142\u2013148","journal-title":"Nat Metab"},{"key":"5568_CR43","first-page":"403","volume":"10434","author":"Q Shi","year":"2024","unstructured":"Shi Q, Wang Y, Hao Q et al (2024) Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials. Lancet 10434:403","journal-title":"Lancet"},{"key":"5568_CR44","doi-asserted-by":"crossref","unstructured":"Perez-Leighton C, Kerr B, Scherer PE et al (2023) The interplay between leptin, glucocorticoids, and GLP1 regulates food intake and feeding behaviour. Biol Rev Camb Philos Soc 99(3): 653\u2013674.","DOI":"10.1111\/brv.13039"},{"key":"5568_CR45","doi-asserted-by":"crossref","unstructured":"Butler J, Shah SJ, Petrie MC et al (2024) Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials. Lancet 403(10437), 1635\u20131648.","DOI":"10.1016\/S0140-6736(24)00469-0"},{"key":"5568_CR46","first-page":"375","volume":"19","author":"SP Marso","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A et al (2016) Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med 19:375","journal-title":"N Engl J Med"},{"key":"5568_CR47","doi-asserted-by":"publisher","first-page":"106550","DOI":"10.1016\/j.phrs.2022.106550","volume":"186","author":"KO Kopp","year":"2022","unstructured":"Kopp KO, Glotfelty EJ, Li Y et al (2022) Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment. Pharmacol Res 186:106550","journal-title":"Pharmacol Res"},{"key":"5568_CR48","doi-asserted-by":"publisher","first-page":"101979","DOI":"10.1016\/j.arr.2023.101979","volume":"89","author":"J Nowell","year":"2023","unstructured":"Nowell J, Blunt E, Gupta D et al (2023) Antidiabetic agents as a novel treatment for Alzheimer\u2019s and Parkinson\u2019s disease. Ageing Res Rev 89:101979","journal-title":"Ageing Res Rev"},{"key":"5568_CR49","first-page":"390","volume":"10103","author":"D Athauda","year":"2017","unstructured":"Athauda D, Maclagan K, Skene SS et al (2017) Exenatide once weekly versus placebo in Parkinson\u2019s disease: a randomised, double-blind, placebo-controlled trial. Lancet 10103:390","journal-title":"Lancet"},{"key":"5568_CR50","first-page":"390","volume":"13","author":"WG Meissner","year":"2024","unstructured":"Meissner WG, Remy P, Giordana C et al (2024) Trial of lixisenatide in early Parkinson\u2019s disease. N Engl J Med 13:390","journal-title":"N Engl J Med"},{"issue":"23","key":"5568_CR51","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1474-4422(23)00378-2","volume":"1","author":"A McGarry","year":"2024","unstructured":"McGarry A, Rosanbalm S, Leinonen M et al (2024) Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson\u2019s disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 1(23):37\u201345","journal-title":"Lancet Neurol"},{"key":"5568_CR52","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1038\/s42255-023-00859-y","volume":"8","author":"R Hanssen","year":"2023","unstructured":"Hanssen R, Rigoux L, Kuzmanovic B et al (2023) Liraglutide restores impaired associative learning in individuals with obesity. Nat Metab 8:1352\u20131363","journal-title":"Nat Metab"},{"key":"5568_CR53","doi-asserted-by":"publisher","first-page":"104896","DOI":"10.1016\/j.neubiorev.2022.104896","volume":"142","author":"S Bhalla","year":"2022","unstructured":"Bhalla S, Mehan S, Khan A et al (2022) Protective role of IGF-1 and GLP-1 signaling activation in neurological dysfunctions. Neurosci Biobehav Rev 142:104896","journal-title":"Neurosci Biobehav Rev"},{"key":"5568_CR54","doi-asserted-by":"crossref","unstructured":"Ghosh P, Fontanella RA, Scisciola L et al (2023) Targeting redox imbalance in neurodegeneration: characterizing the role of GLP-1 receptor agonists, Theranostics 14. 13 : 4872\u20134884","DOI":"10.7150\/thno.86831"},{"key":"5568_CR55","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/alz.12474","volume":"3","author":"HN Yassine","year":"2022","unstructured":"Yassine HN, Solomon V, Thakral A et al (2022) Brain energy failure in dementia syndromes: Opportunities and challenges for glucagon-like peptide-1 receptor agonists. Alzheimers Dement 3:478\u2013497","journal-title":"Alzheimers Dement"},{"key":"5568_CR56","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jocn.2020.09.054","volume":"81","author":"YF Chang","year":"2020","unstructured":"Chang YF, Zhang D, Hu WM et al (2020) Semaglutide-mediated protection against A\u03b2 correlated with enhancement of autophagy and inhibition of apotosis. J Clin Neurosci 81:234\u2013239","journal-title":"J Clin Neurosci"},{"key":"5568_CR57","doi-asserted-by":"publisher","first-page":"109716","DOI":"10.1016\/j.neuropharm.2023.109716","volume":"240","author":"ZJ Wang","year":"2023","unstructured":"Wang ZJ, Li XR, Chai SF et al (2023) Semaglutide ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer\u2019s disease via the GLP-1R\/SIRT1\/GLUT4 pathway. Neuropharmacology 240:109716","journal-title":"Neuropharmacology"},{"key":"5568_CR58","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00125-022-05730-5","volume":"9","author":"J Bailey","year":"2022","unstructured":"Bailey J, Coucha M, Bolduc DR et al (2022) GLP-1 receptor nitration contributes to loss of brain pericyte function in a mouse model of diabetes. Diabetologia 9:1541\u20131554","journal-title":"Diabetologia"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05568-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05568-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05568-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T10:02:58Z","timestamp":1784282578000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05568-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":58,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["5568"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05568-0","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"2 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were approved by the ethical committee on animal welfare of Shanghai Sixth People\u2019s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine in accordance with the principles outlined in the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}